Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 7

1.

Mental health policy and psychotropic drugs.

Frank RG, Conti RM, Goldman HH.

Milbank Q. 2005;83(2):271-98. Review.

PMID:
15960772
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Understanding the use of psychotropic medications in the child welfare system: causes, consequences, and proposed solutions.

Alavi Z, Calleja NG.

Child Welfare. 2012;91(2):77-94. Review.

PMID:
23362615
[PubMed - indexed for MEDLINE]
3.

Generic psychotropic medications: issues of cost-effectiveness and patient benefit.

Ladue L.

South Med J. 2011 Oct;104(10):711-4. doi: 10.1097/SMJ.0b013e31822cf1ea. Review.

PMID:
21941162
[PubMed - indexed for MEDLINE]
4.

The importance of considering non-monetary costs and benefits in selecting pharmacologic interventions in mental health.

Pleil AM.

Psychopharmacol Bull. 1995;31(4):727-34. Review.

PMID:
8851646
[PubMed - indexed for MEDLINE]
5.

Private insurance coverage for the treatment of mental illness versus general medical care: a policy of inequity.

Tommasini NR.

Arch Psychiatr Nurs. 1994 Feb;8(1):9-13. Review.

PMID:
8203946
[PubMed - indexed for MEDLINE]
6.

Negotiating the new health system: purchasing publicly accountable managed care.

Rosenbaum S.

Am J Prev Med. 1998 Apr;14(3 Suppl):67-71. Review.

PMID:
9566940
[PubMed - indexed for MEDLINE]
7.

Antidepressants and advertising: psychopharmaceuticals in crisis.

Greenslit NP, Kaptchuk TJ.

Yale J Biol Med. 2012 Mar;85(1):153-8. Epub 2012 Mar 29. Review.

PMID:
22461754
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk